Is Sansheng Pharmaceutical worth going to?

Because Sansheng Pharmaceutical has a bright future, Sansheng has 6.5 billion cash and more than one billion cash inflows every year. If the company wants to make a breakthrough in innovative drugs in the future, it can also seek to acquire high-quality products or companies, and the market does not give any valuation.

Sansheng Pharmaceutical Group is a leading biopharmaceutical enterprise integrating R&D, production and sales, and is committed to the research and development of recombinant protein drugs by genetic engineering.